Wrinkles, folds and calcifications: Reduced durability after transcatheter aortic valve-in- valve replacement  Herko Grubitzsch, MD, PhD, Marco Galloni,

Slides:



Advertisements
Similar presentations
Tubular heart valves: A new tissue prosthesis design—Preclinical evaluation of the 3F aortic bioprosthesis James L. Cox, MD, Niv Ad, MD, Keith Myers, BS,
Advertisements

Davide Gabbieri, MD, Pascal M
Transcatheter aortic valve replacement in patients with severe aortic stenosis who are at high risk for surgical complications: Summary assessment of.
Max B. Mitchell, MD  The Journal of Thoracic and Cardiovascular Surgery 
Of mice and men and surgical transcatheter aortic valve insertion
Aortic valve replacement in low-flow, low-gradient aortic stenosis: Left ventricular ejection fraction matters  Victor Dayan, MD, PhD, Philippe Pibarot,
Early structural valve deterioration of the Trifecta aortic valve biological prosthesis: A word of caution  Pankaj Saxena, FRACS, PhD, Kevin L. Greason,
Aborted episode of sudden death due to delayed heart block after transcatheter aortic valve insertion  Kevin L. Greason, MD, Paul A. Friedman, MD, Daniel.
Three-dimensional template-based planning for transapical aortic valve implantation  Stephan Jacobs, MD, PhD, Michael Gessat, PhD, Thomas Walther, MD,
Harald C. Eichstaedt, MD, Jerry Easo, MD, Tobias Härle, MD, Otto E
Bigger valve size is not always better
Long-term follow-up after aortic valve replacement with Edwards Prima Plus stentless bioprostheses in patients younger than 60 years of age  Torsten Christ,
Intrinsic cardiac stem cells are essential for regeneration
Reoperative “valve-in-valve” transapical transcatheter mitral valve replacement in a high-risk patient with a recent transapical transcatheter aortic.
Trileaflet aortic valve reconstruction with a decellularized pericardial patch in a sheep model  Bart Meuris, MD, PhD, Shigeyuki Ozaki, MD, PhD, William.
Early degeneration of the St Jude Medical Trifecta bioprosthetic aortic valve: A problem of the leaflets or of the stent?  Giuseppe Santarpino, MD, Steffen.
Aortic valve implantation with the CoreValve ReValving System via left carotid artery access: First case report  Thomas Modine, MD, Gilles Lemesle, MD,
Quadruple valve replacement in patients with carcinoid heart disease
Bicuspid aortic valve aortopathy: One size fits all?
Jennifer S. Lawton, MD, Nader Moazami, MD, Michael K
Right anterior minithoracotomy aortic valve replacement with a sutureless bioprosthesis: Early outcomes and 1-year follow-up from 2 European centers 
A novel hybrid technique for transcatheter pulmonary valve implantation within a dilated native right ventricular outflow tract  Frances C. Travelli,
Biventricular root replacement for transcatheter pulmonary valve endocarditis after Ross operation: Double the trouble  T.K. Susheel Kumar, MD, Kaitlin.
Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement  Ole Lund, MD, PhD, Martin Bland,
The lord of the rings  Antonio Miceli, MD, PhD 
The variability of the mitral valve anatomy and terminology
Support Your Specialty
Transcatheter aortic valve replacement in intermediate-risk patients
Innovation and science: The future of valve design
Sometimes an ounce of extracorporeal membrane oxygenation prevention is worth a pound of extracorporeal membrane oxygenation cure  Pankaj Saxena, FRACS,
Aortic valve replacement with the Mitroflow pericardial bioprosthesis: Durability results up to 21 years  Charles A. Yankah, MD, PhD, Miralem Pasic, MD,
Michele Gallo, MD, Gino Gerosa, MD 
Transcatheter aortic valve replacement and surgical aortic valve replacement: Both excellent therapies  J. James Edelman, MBBS(Hons), PhD, Vinod H. Thourani,
Sitaram M. Emani, MD, Breanna L
Surgery for aortic and mitral valve disease in the United States: A trend of change in surgical practice between 1998 and 2005  Scott D. Barnett, PhD,
Henry M. Spotnitz, MD, Daniel Y. Wang, MD 
Meghana R. K. Helder, MD, Nicholas T
Luca A. Vricella, MD, Duke E. Cameron, MD 
Kevin Bridge, MD, MSPH, Robert Saeid Farivar, MD, PhD 
Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD 
The Journal of Thoracic and Cardiovascular Surgery
In search of the smoking gun in calcific aortic valve disease
Replicating the success of mitral valve repair in the aortic valve
A fate worse than death  Jennifer S. Lawton, MD 
Commentary: Bioprosthetic aortic valve replacement: A high standard of comparison for transcatheter aortic valve implantation  Aaron Martin, MD, Michael.
Thrombosis following mitral and tricuspid valve-in-valve replacement
Passing the torch The Journal of Thoracic and Cardiovascular Surgery
Biomaterials for heart valve replacement: Conjectures and refutations
Postimplantation morphologic changes of glutaraldehyde-fixed porcine aortic roots and risk of aneurysm and rupture  Tirone E. David, MD, Susan Armstrong,
The Mitroflow aortic valve: A past, present, and future illuminated
Hans-Joachim Schäfers, MD 
Transcatheter aortic valve replacement for prime time unrestricted distribution? Not so fast, my friend  G. Michael Deeb, MD, John Carroll, MD  The Journal.
The harder one looks, the more one finds
Concomitant replacement of the ascending aorta is free—for some
Preserving the V-engine shape of the left ventricle with Melody mitral valve replacement in small children  Patrick O. Myers, MD  The Journal of Thoracic.
The Journal of Thoracic and Cardiovascular Surgery
Discussion The Journal of Thoracic and Cardiovascular Surgery
Tissue valve, nitinol stent, or storage solution
The future of cardiac surgery training: A survival guide
Permanent pacemaker insertion following transcatheter aortic valve replacement: Not infrequent, not benign, and becoming predictable  Craig M. Jarrett,
Commentary: When a choice is not an echo
“The more things change…”: The challenges ahead
Intermittent incomplete closure of Medtronic Advantage aortic valve leaflets causes unnecessary reoperation  Rune Haaverstad, MD, PhD, Nicola Vitale,
Transcatheter aortic valve implantation: The European experience
Lessons from the first patient to undergo full aortic root replacement using a homograft: A 29-year follow-up  Sajiram Sarvananthan, MBBS, Giovanni Melina,
Effect of transcatheter aortic valve size and position on valve-in-valve hemodynamics: An in vitro study  Vinayak N. Bapat, FRCS(CTh)  The Journal of.
Journal changes and initiatives
Lessons learned from Melody valve retrieved at transplantation
Zone zero thoracic endovascular aortic repair is all about “location, location, location”  Kevin L. Greason, MD  The Journal of Thoracic and Cardiovascular.
Paul Philipp Heinisch, MD, Thierry Carrel, MD 
Presentation transcript:

Wrinkles, folds and calcifications: Reduced durability after transcatheter aortic valve-in- valve replacement  Herko Grubitzsch, MD, PhD, Marco Galloni, MSc, Volkmar Falk, MD, PhD  The Journal of Thoracic and Cardiovascular Surgery  Volume 153, Issue 2, Pages 266-268 (February 2017) DOI: 10.1016/j.jtcvs.2016.08.018 Copyright © 2016 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Early structural failure after transcatheter aortic valve-in-valve replacement. A, Section of patient's chest radiograph showing a 23-mm CoreValve transcatheter valve (Medtronic, Minneapolis, Minn) within a 21-mm Mitroflow conventional stented bioprosthesis (LivaNova PLC, London, United Kingdom). B, The explanted CoreValve-Mitroflow-corpus presenting pericardial folds and vegetating calcifications at the outflow aspects. C, Wrinkled pericardium and calcifications at the inflow aspect of the explanted CoreValve prosthesis. D, Radiographic examination demonstrates an ovalized, noncircular cross-sectional profile of the transcatheter valve within the stented bioprosthesis, as well as multiple calcifications at all leaflets of the CoreValve prosthesis. E, Alizarin red staining of a leaflet fold with intrinsic calcium nodule (3-fold magnification). F, Hematoxylin-eosin staining of a leaflet fold showing homogenized and locally disrupted collagen bundles, a bubbly tissue texture, and pericardial delamination (20-fold magnification). The Journal of Thoracic and Cardiovascular Surgery 2017 153, 266-268DOI: (10.1016/j.jtcvs.2016.08.018) Copyright © 2016 The American Association for Thoracic Surgery Terms and Conditions

Incomplete expansion and calcification after transcatheter valve-in-valve replacement. The Journal of Thoracic and Cardiovascular Surgery 2017 153, 266-268DOI: (10.1016/j.jtcvs.2016.08.018) Copyright © 2016 The American Association for Thoracic Surgery Terms and Conditions

Video 1 Fluoroscopy demonstrating the degenerated 21-mm Mitroflow prosthesis (LivaNova PLC, London, United Kingdom) and the valve-in-valve procedure with a 23-mm CoreValve prosthesis (Medtronic, Minneapolis, Minn). Video available at: http://www.jtcvsonline.org/article/S0022-5223(16)31037-6/addons. The Journal of Thoracic and Cardiovascular Surgery 2017 153, 266-268DOI: (10.1016/j.jtcvs.2016.08.018) Copyright © 2016 The American Association for Thoracic Surgery Terms and Conditions